Stay updated on ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial page.

Latest updates to the ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial page
- Check3 days agoChange DetectedThe page now shows a 403 Forbidden error with a minimal header/footer instead of the study details. This indicates an access issue rather than a content update to the study record.SummaryDifference19%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page adds a U.S. NIH Grant/Contract funding note and updates the page revision to v3.6.6 (replacing the previous v3.6.5).SummaryDifference0.1%

- Check45 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a version update to the page content. This appears to be a minor maintenance/QA update rather than a change to the study details.SummaryDifference0.1%

- Check60 days agoChange DetectedThe revision tag on the page was updated from v3.6.3 to v3.6.4, indicating a new revision has been applied.SummaryDifference0.1%

- Check82 days agoChange DetectedThe site displays an updated revision tag (v3.6.3) replacing the previous version (v3.6.2), indicating a minor update to the page’s implementation.SummaryDifference0.1%

- Check89 days agoChange DetectedThe page's revision history now shows the latest revision as v3.6.2, replacing the previous v3.6.0.SummaryDifference0.1%

Stay in the know with updates to ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial page.